Metoclopramide

Gastroparesis, Aerophagy, Migraine + 23 more
Treatment
4 FDA approvals
20 Active Studies for Metoclopramide

What is Metoclopramide

MetoclopramideThe Generic name of this drug
Treatment SummaryMetoclopramide is a medication used to treat nausea, vomiting, and other symptoms caused by diabetic gastroparesis. It is also used to treat nausea and vomiting caused by chemotherapy or certain medical procedures. Unlike some other medications, metoclopramide does not increase stomach acid production. It comes in tablet and liquid form and can also be given intravenously. Metoclopramide was first approved by the FDA in 1980.
Metoclopramideis the brand name
image of different drug pills on a surface
Metoclopramide Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Metoclopramide
Metoclopramide
1985
199

Approved as Treatment by the FDA

Metoclopramide, commonly known as Metoclopramide, is approved by the FDA for 4 uses including Gastroesophageal reflux disease and Gastroesophageal Reflux Disease (GERD) .
Gastroesophageal reflux disease
Gastroesophageal Reflux Disease (GERD)
Failed conventional therapy
Gastroparesis

Effectiveness

How Metoclopramide Affects PatientsMetoclopramide helps food pass through your digestive system by reducing the pressure of the lower esophageal sphincter. It also helps prevent and reduce symptoms of nausea and vomiting. It increases digestive activity without increasing the amount of acid produced in the stomach, bile, or pancreas. However, it should not be taken for longer than 12 weeks since it can cause tardive dyskinesia (TD), dystonia, and akathisia.
How Metoclopramide works in the bodyMetoclopramide works to prevent nausea and vomiting by blocking dopamine and serotonin receptors in the brain. It also increases the amount of acetylcholine released, which helps to speed up digestion and reduce stomach discomfort. Metoclopramide also works by blocking dopamine receptors, which can help to relax the gastrointestinal tract.

When to interrupt dosage

The prescribed measure of Metoclopramide is reliant upon the identified illness, including Nausea, Intubation (process) and Gastroesophageal Reflux Disease (GERD). The dosage may differ, as indicated by the administration technique (e.g. Spray or Tablet, orally disintegrating) listed in the table beneath.
Condition
Dosage
Administration
gastric emptying for radiologic procedures
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
radiation therapy induced nausea and vomiting
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Gastric Motility Disorder
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Hyperacidity
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
meteorism
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Therapeutic procedure
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Nausea
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
prophylaxis of Hiccups
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Acute Coryza
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Nausea
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Failed conventional therapy
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Nausea
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Aerophagy
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Flatulence
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Indigestion
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Gastrointestinal distress
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Hiccup
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Nausea
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Pharmacotherapy
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous
Intubation (procedure)
10.0 mg, , 5.0 mg, 5.0 mg/mL, 10.0 mg/mL, 1.0 mg/mL, 1.0 mg, 9.0 mg/mL, 1500.0 mg/mL
, Oral, Tablet - Oral, Tablet, Solution, Solution - Oral, Intramuscular; Intravenous, Injection, Injection - Intramuscular; Intravenous, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Injection, solution, Injection, solution - Intramuscular; Intravenous, Intravenous, Injection - Intravenous, Liquid, Liquid - Intramuscular; Intravenous, Syrup, Syrup - Oral, Liquid - Oral, Liquid - Intravenous, Injection, solution - Intravenous, Oral; Topical, Kit, Kit - Oral; Topical, Spray, Spray - Nasal, Nasal, Solution - Intramuscular; Intravenous

Warnings

Metoclopramide Contraindications
Condition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Metoclopramide may interact with Pulse Frequency
Mechanical Intestinal Obstruction
Do Not Combine
Gastrointestinal Hemorrhage
Do Not Combine
Gastrointestinal Perforation
Do Not Combine
Paraganglioma
Do Not Combine
Tardive Dyskinesia
Do Not Combine
Pharmaceutical Preparations
Do Not Combine
Pheochromocytoma
Do Not Combine
Parkinson's Disease
Do Not Combine
Depression
Do Not Combine
Epilepsy
Do Not Combine
Gastrectomy
Do Not Combine
Dystonia
Do Not Combine
Feeling suicidal (finding)
Do Not Combine
There are 20 known major drug interactions with Metoclopramide.
Common Metoclopramide Drug Interactions
Drug Name
Risk Level
Description
Acepromazine
Major
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Acepromazine.
Aceprometazine
Major
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Aceprometazine.
Acetophenazine
Major
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Acetophenazine.
Alimemazine
Major
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Alimemazine.
Amisulpride
Major
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Amisulpride.
Metoclopramide Toxicity & Overdose RiskMetoclopramide has a toxic dose of 750mg/kg in rats. An overdose on metoclopramide can cause drowsiness, confusion, and muscle control problems. To treat these symptoms, drugs used for Parkinson's disease or antihistamines with anticholinergic properties may be used. In some cases, these symptoms may last up to 24 hours. Unintentional overdose in infants can lead to seizures, muscle control issues, and a weak state. Additionally, methemoglobinemia (a rare blood disorder) can occur after an overdose. To treat this, methylene blue may be administered. However
image of a doctor in a lab doing drug, clinical research

Metoclopramide Novel Uses: Which Conditions Have a Clinical Trial Featuring Metoclopramide?

113 active clinical trials are presently evaluating the potential of Metoclopramide to alleviate Migraine, Nausea and as an adjunct in Pharmacotherapy.
Condition
Clinical Trials
Trial Phases
Gastroparesis
18 Actively Recruiting
Phase 3, Not Applicable, Phase 2, Phase 1, Early Phase 1
Migraine
52 Actively Recruiting
Phase 4, Not Applicable, Phase 2, Phase 1, Phase 3, Early Phase 1
Gastric Acid
0 Actively Recruiting
Gastroesophageal Reflux Disease (GERD)
14 Actively Recruiting
Not Applicable, Phase 2
Flatulence
0 Actively Recruiting
Therapeutic procedure
0 Actively Recruiting
Pharmacotherapy
0 Actively Recruiting
Indigestion
6 Actively Recruiting
Phase 3, Phase 2, Not Applicable, Phase 4
radiation therapy induced nausea and vomiting
0 Actively Recruiting
Nausea
0 Actively Recruiting
Gastrointestinal distress
7 Actively Recruiting
Phase 2, Phase 1, Phase 3, Early Phase 1, Not Applicable
Hiccup
0 Actively Recruiting
Failed conventional therapy
0 Actively Recruiting
meteorism
0 Actively Recruiting
Nausea
0 Actively Recruiting
Gastric Motility Disorder
0 Actively Recruiting
Aerophagy
0 Actively Recruiting
Intubation (procedure)
0 Actively Recruiting
gastric emptying for radiologic procedures
0 Actively Recruiting
prophylaxis of Hiccups
0 Actively Recruiting

Metoclopramide Reviews: What are patients saying about Metoclopramide?

5Patient Review
6/13/2017
Metoclopramide for Condition in which Stomach Acid is Pushed Into the Esophagus
I've been taking this medication for nearly a decade, and have only just now realized that it has caused my breasts to grow larger and my sex drive to dwindle. As a man, this was never explained to me by the doctor prescribing the drug, and I feel like it amounts to criminal negligence.
4.7Patient Review
1/19/2017
Metoclopramide for Condition in which Stomach Acid is Pushed Into the Esophagus
I had great results for the three weeks I took this medication. It stopped my acid reflux and helped slow my diarrhea, but now the pharmacy says I can't renew it.
4Patient Review
12/4/2019
Metoclopramide for Condition in which Stomach Acid is Pushed Into the Esophagus
I've been on this medication for a while now and it seems to be helping, though I am concerned about how long I've been taking it. From what I can tell, it's supposed to be temporary.
3Patient Review
2/2/2019
Metoclopramide for Nausea and Vomiting
I was prescribed this to help with pregnancy-related nausea and vomiting. It worked for two days, at which point I stopped taking it due to the deep all-day migraine it caused, as well as toothache pain.
2.7Patient Review
10/21/2021
Metoclopramide for Condition in which Stomach Acid is Pushed Into the Esophagus
I felt incredibly drowsy after taking this drug, to the point where I couldn't speak properly. My stomach also felt empty and I was overall quite tired.
View All Reviews
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about metoclopramide

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is metoclopramide used for?

"Metoclopramide can help with nausea and vomiting caused by cancer treatment, migraines, or other conditions."

Answered by AI

Is metoclopramide the same as Zofran?

"The brand names for ondansetron are Zofran, Zofran ODT, and Zuplenz. The brand names for metoclopramide are Reglan and Metozolv ODT. Ondansetron and metoclopramide are in different drug classes. Ondansetron is an anti-nausea medication and metoclopramide is a "prokinetic" drug."

Answered by AI

What class of drugs is metoclopramide?

"Oct 15, 2018Metoclopramide belongs to a class of medications called prokinetic agents. It works by speeding up the movement of food through the stomach and intestines."

Answered by AI

What are the side effects of metoclopramide?

"The following effects may occur: drowsiness, dizziness, tiredness, trouble sleeping, agitation, headache, and diarrhea. If you experience any of these effects for an extended period of time, or if they get worse, tell your doctor or pharmacist."

Answered by AI

Clinical Trials for Metoclopramide

Have you considered Metoclopramide clinical trials? We made a collection of clinical trials featuring Metoclopramide, we think they might fit your search criteria.
Have you considered Metoclopramide clinical trials? We made a collection of clinical trials featuring Metoclopramide, we think they might fit your search criteria.
Have you considered Metoclopramide clinical trials? We made a collection of clinical trials featuring Metoclopramide, we think they might fit your search criteria.